Saturn V Capital Management’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-172,188
Closed -$1.76M 23
2023
Q1
$1.76M Sell
172,188
-512,808
-75% -$5.86M 1.31% 16
2022
Q4
$9.89M Buy
+684,996
New +$9.66M 8.2% 2

Other funds holding TSVT

Saturn V Capital Management's TSVT Position: Q2 2023 in Review

Saturn V Capital Management sold out of 2seventy bio (TSVT) in Q2 2023, closing a stake of 172,188 shares — an estimated $1.76M sold.

Saturn V Capital Management first reported a position in TSVT in Q4 2022 and held it in 2 quarters. The position peaked at $9.89M in Q4 2022. 149 funds tracked by Wall St. Rank hold TSVT as of Q2 2023.

  • Saturn V Capital Management reported no remaining 2seventy bio position as of Q2 2023 after selling out during the quarter.
  • Saturn V Capital Management sold 172,188 2seventy bio shares in Q2 2023, an estimated $1.76M.
  • Saturn V Capital Management first reported a position in 2seventy bio in Q4 2022 and held it in 2 quarters.
  • Saturn V Capital Management's 2seventy bio position peaked at $9.89M in Q4 2022.
  • 149 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2023.

Based on Saturn V Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.